Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 09, 2026 07:00 ET | Source: SparingVision

SparingVision Successfully Completes PRODYGY Trial Patient Dosing with SPVN06, its Novel Neuroprotective Gene Therapy

All patients dosed with SPVN06 in Phase I/II trial continue to demonstrate a favorable safety profileInitial data readout for this novel gene-agnostic therapy expected in 2027 Paris, February 9,...
February 06, 2026 05:39 ET | Source: Research and Markets

$42.41 Bn Ophthalmology Devices Markets - Global Forecast Report 2026-2032 - Opportunities in Advanced Diagnostics, Minimally Invasive Surgery, and Intraocular Optics

Dublin, Feb. 06, 2026 (GLOBE NEWSWIRE) -- The "Ophthalmology Devices Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. In 2025, the ophthalmology...
February 04, 2026 08:01 ET | Source: Nextech Systems, Inc.

Nextech Wins 2026 Best in KLAS for Ambulatory Ophthalmology Solutions

Tampa, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Nextech, an award-winning technology partner for specialty practices and med spas, announced today it has been recognized in the 2026 Best in KLAS®...
February 01, 2026 21:00 ET | Source: Arctic Vision (Cayman) Limited

Arctic Vision Announces Deal to Integrate MDCO Technology’s Ophthalmic Device Business to Form a Global Drug–Device Innovation Platform

SHANGHAI, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Headquartered in Shanghai, Arctic Vision (Cayman) Limited (“Arctic Vision”), a global ophthalmic company, announced that it has entered into an agreement...
January 30, 2026 11:30 ET | Source: OKYO Pharma LTD

OKYO Pharma Announces Acceptance of Urcosimod Phase 2 Study Results for Presentation at Prestigious ASCRS Annual Meeting

LONDON and NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of...
January 28, 2026 07:40 ET | Source: OKYO Pharma LTD

OKYO Pharma Announces Successful Type C Meeting with the FDA

LONDON and NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of...
January 28, 2026 07:27 ET | Source: Research and Markets

Persistent Epithelial Defect Market - A Global and Regional Analysis: Focus on End User and Region, 2025-2035

Dublin, Jan. 28, 2026 (GLOBE NEWSWIRE) -- The "Persistent Epithelial Defect Market - A Global and Regional Analysis: Focus on End User and Region, 2025-2035" has been added to ...
January 27, 2026 09:00 ET | Source: Nextech Systems, Inc.

Nextech Pioneers New Era in Clinical Documentation with Launch of AI-Powered Cora Scribe

Tampa, Fla., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Specialty-specific clinical documentation requires more than a generic, automated note taker to truly improve the charting process. Today, Nextech – an...
January 23, 2026 05:13 ET | Source: Research and Markets

Ophthalmology EMR Software Market - Global Forecast 2026-2032

Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "Ophthalmology EMR Software Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Ophthalmology EMR Software...
January 22, 2026 11:08 ET | Source: Research and Markets

Ophthalmology PACS Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

Dublin, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The "Ophthalmology PACS Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ResearchAndMarkets.com's...